Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
The peptide-based vaccine induces a t cell-dependent response
The association has lined up a string of prominent speakers from the government and private sector. Seasoned veterans and industry bigwigs will grace the two-day event in Mumbai
A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Both companies have been selected for stand-by production by German government
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Subscribe To Our Newsletter & Stay Updated